Industrial & Environmental

The Section develops biotechnology industry policy on environmental and industrial biotechnology issues, promotes the use of industrial enzymes, conversion of biomass to energy and chemicals and innovative clean up technologies. The Section works closely with the U.S. Congress, federal agencies, and international organizations. The Section is active in promoting technologies that promote sustainable development. The Section also is involved with legislative and regulatory issues related to the use of industrial enzymes in manufacturing processes and with environmental biotechnology products used for environmental remediation. Principal federal regulatory agencies: DOE, EPA and USDA.
Staff Contact: Brent Erickson


Christopher Standlee, I&E Section Chair
Abengoa Bioenergy

Eli Ben-Shoshan
DuPont Industrial Biosciences

Doug Berven
Poet, LLC

Tjerk de Ruiter

Neil Goldsmith

Mark Jones, PhD
Dow Chemical Company

Michael Knutzen
The Coca Cola Company

Adam Monroe

Markus Pompejus
BASF Corporation

Anna Rath

Joseph Shaulson
Metabolix, Inc

Stephan B. Tanda
DSM Pharmaceutical Products

Marc Verbruggen, PhD
NatureWorks, LLC

Jonathan S. Wolfson, JD, MBA
Solazyme, Inc